Brief: MEI Pharma Reports Fiscal Year End 2024 Cash Position
19/09/2024 21:04
Sept 19 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA REPORTS FISCAL YEAR END 2024 CASH POSITION
* MEI PHARMA INC - CONFIRMS CONTINUATION OF EVALUATION OF
STRATEGIC ALTERNATIVES
* MEI PHARMA INC - WILL CONSIDER OPTIONS SUCH AS
OUT-LICENSING
OPPORTUNITIES FOR EXISTING PROGRAMS AND MERGER AND ACQUISITION
OPPORTUNITIES
Source text for Eikon: ID:nBw7ddfSDa
Further company coverage: MEIP.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations